Inspire® Post-Approval Study / Protocol Number 2014-001
← catalyst calendarSponsored by Inspire Medical Systems, Inc. (industry) · INSP — their whole pipeline →.
Phase
Not applicable
Status
Unknown status
Study type
Interventional
Design
Na · None · Treatment
Enrollment
127actual
Sites
14
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | May 2015 | actual | When the study began enrolling |
| Primary completion | Mar 2025 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jun 2025 | estimated | The whole study's end, after follow-up |
| First posted | 2015-04-10 | estimated | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2024-12-27 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Obstructive Sleep Apnea
Intervention
- Device: Inspire® UAS System — also filed as Inspire® therapy
Primary outcomes
what the primary-completion date above is the date OFLong-term Device-Related SAEs
measured 5 Years Post-Implant
Therapy Specific AEs
measured 12 Months Post-Implant
Long-term Therapy-Related AEs
measured 5 Years Post-Implant
Permalink · INSP's whole pipeline · Catalyst calendar · Every registered study · What changed